Which condition is NOT included in the HAS-BLED score?

The HAS-BLED score is a clinical tool used to assess the risk of bleeding in patients who are on anticoagulation therapy, particularly those with atrial fibrillation. Each component of the HAS-BLED score highlights factors that contribute to bleeding risks.

This score includes indicators such as abnormal liver function, labile international normalized ratios (INRs), and use of drugs or alcohol, each of which has a documented association with increased bleeding risks. Abnormal liver function points to potential hepatic impairment and associated coagulation issues, labile INRs reflect difficulties in managing anticoagulation levels, and drug or alcohol use can affect platelet function and liver metabolism, further heightening bleeding risks.

The history of myocardial infarction, although a relevant cardiovascular risk factor, is not included in the HAS-BLED score. It does not have a direct correlation with bleeding tendencies like the other factors mentioned. Thus, selecting history of myocardial infarction as the condition not included in the HAS-BLED score aligns correctly with the underlying criteria for assessing bleeding risk.